Últimas noticias sobre Health Catalyst (NASDAQ:HCAT) Bolsa

Health Catalyst

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Health Catalyst Inc

WIIM

TIVC

Tivic Health Systems shares are trading lower after the company reported a year-over-year decline in Q3 sales results.

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>) with a Buy and maintains $12 price target.

News

Price Target

Analyst Ratings

QNCX

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $12 Price Target

Earnings

OCTO

Eightco Holdings Q3 Sales $7.7M Down From $23.3M YoY

Traws Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) reported quarterly losses of $(8.81) per share which missed the analyst consensus estimate of $(6.12) by 43.95 percent. The company reported quarterly sales of $57.000 million which beat the analyst consensus estimate of $58.000 thousand by 98.18K percent.

Earnings Beats

Earnings Misses

TRAW

Traws Pharma Q3 2024 GAAP EPS $(8.81) Misses $(6.12) Estimate, Sales $57.000M Beat $58.000K Estimate

Trading Ideas

GOOGL

UBER

Third Point 13F Shows Exited Position In Alphabet, Previously Holding 1,980,000 Shares; American Intl Group, Previously Holding 3,450,000 Shares; Verizon Communications, Previously Holding 4,675,000 Shares; Uber Technologies Inc, Previously Holding 2,100,000 Shares; KB Home, Previously Holding 2,100,000 Shares

Billionaire investor Warren Buffett cut several of Berkshire Hathaway Inc&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) <a href="https://www.benzinga.com/markets/equities/24/08/40232279/is-warren-buffett-bearish-or-waiting-to-pounce-berkshire-now-owns-more-t-bills-than-federal-rese">largest holdings this year</a>. 
The Omaha, Nebraska-based holding company&#8217;s latest 13F filing shows that the sell-off trend continues.
What Happened: Berkshire&#8217;s latest 13F filing, filed on Thursday, reflects the company&#8217;s largest holdings as of September 30.
Buffett reduced his stake in Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) from 400 million to 300 million shares. Thus, Berkshire has now cut its position in the Cupertino, California-based tech giant by over two-thirds since 2023&#8217;s third quarter.
The Omaha &#8220;oracle&#8221; also continued to cut his stake in Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), trimming back another 23% of Berkshire&#8217;s position.
Berkshire cut nearly all of its position in Ulta Beauty Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>). Buffett <a href="https://www.benzinga.com/markets/equities/24/08/40385824/warren-buffett-still-holds-400m-apple-shares-reveals-new-investments-in-ulta-beauty-and-heico-el">revealed a position in the cosmetic store chain</a> in August; the company&#8217;s stock has performed roughly even since then. Buffett&#8217;s Ulta holding period was unusually short for the famed value investor.
Meanwhile, Buffett added a couple of fresh faces to Berkshire&#8217;s portfolio.
Buffett bought 1,277,256 shares of Ann Arbor, Michigan-based pizza chain Domino&#8217;s Pizza Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>). He also made a foray into pool equipment, buying 404,057 shares of Pool Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NASDAQ">POOL</a>).
Price Action: Investors quickly reacted to Berkshire&#8217;s 13F filing after hours:
<ul>
<li>Dominoes Pizza shares traded up nearly 7%.</li>
<li>Pool Corp shares traded up nearly 6%.</li>
<li>Ulta Beauty shares fell over 4%.</li>
<li>Apple and Bank of America shed insignificant portions of their market value.</li>
</ul>
Why it Matters: During Berkshire&#8217;s annual shareholder meeting in May, Buffett hinted that his sell-offs were a result of tax implications. 
This <a href="https://www.benzinga.com/markets/equities/24/08/40385824/warren-buffett-still-holds-400m-apple-shares-reveals-new-investments-in-ulta-beauty-and-heico-el">has not stopped</a> investors&#8217; conjecture that Buffett is perhaps bearish <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">on the market at large</a>.
Alternatively, Buffett could be simply trimming positions that take up an outsized portion of Berkshire&#8217;s portfolio to reduce exposure.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41988194/trump-plans-to-erase-ev-tax-credit-analyst-says-its-net-bullish-calls-sell-off-wrong-knee-jerk-reaction">Trump Plans To Erase EV Tax Credit: Tesla Analyst Says It&#8217;s &#8216;Net Bullish,&#8217; Calls Sell-Off &#8216;Wrong Knee-Jerk Reaction&#8217;</a></li>
</ul>
Image via Flickr

Equities

AAPL

POOL

ULTA

Warren Buffett's Berkshire Hathaway Slashes Apple, BofA Holdings, Adds Domino's Pizza In Q3

LGCY

Legacy Education shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.55) by 12.73 percent.

BNTC

Benitec Biopharma Q1 2025 GAAP EPS $(0.48) Beats $(0.55) Estimate

MLSS

Milestone Scientific shares are trading higher after the company reported better-than-expected Q3 financials.

Hedge Funds

General

MRCY

Starboard Value's Q3 2024 13F Filing Reveals Complete Exits From Mercury Systems With 2.29M Shares, AECOM With 625K Shares

BENF

Beneficient shares are trading higher after the company reported a year-over-year increase in Q2 revenue results.

OPTX

Syntec Optics Holdings Q3 EPS $0.00 Down From $0.01 YoY, Sales $7.86M Up From $6.6M YoY

Billionaire investor Chase Coleman's hedge fund, Tiger Global Management, filed its latest <a href="https://www.sec.gov/Archives/edgar/data/1167483/000091957424006690/xslForm13F_X02/infotable.xml">Form 13F</a> on Thursday and disclosed its trading activity from the prior quarter. Here's a look at Tiger Global's <a href="https://www.benzinga.com/opinion/24/08/40422936/steal-these-two-stock-ideas-from-the-best-investors-in-the-world">portfolio changes.&nbsp;</a>
The Details: Tiger Global has $23.439 billion in assets under management and made no changes to its top five holdings:&nbsp;
<ul>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) </li>
<li>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) </li>
<li>Alphabet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) </li>
<li>Apollo Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) </li>
<li>Sea Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) </li>
</ul>
Read Next: <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a>
New Positions: Tiger Global opened three new positions including a $801.3 million stake in Flutter Entertainment Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>), the parent company of FanDuel. The fund also opened a $201.4 million position in Sherwin-Williams Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) and a $48.9 million position in South Korean e-commerce platform Coupang, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>). 
Notable Trades: Tiger Global added 564,090 shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) to its portfolio, bringing its total number of shares owned to 3,634,980. The fund also increased its stake in Take-Two Interactive Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) by 195,714 shares, bringing its current holdings to 5,839,256 shares valued at $897.5 million. 
Closed Positions: The hedge fund closed out its positions in Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) and DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Image created using artificial intelligence via MidJourney.

Movers

ALAB

CPNG

DXCM

FLUT

MSFT

TTWO

Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom

RVYL

Ryvyl shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY24 sales guidance.

BLMN

GDDY

Starboard Value's Q3 2024 13F Filing Shows Reduced Stakes In GoDaddy By 32% To 3.13M Shares, Salesforce By 14% To 1.44M Shares, Humana By 62% To 191K Shares, And Bloomin' Brands By 14%

AMZN

Third Point 13F Shows Decreased Stake In PG&E Corp By 7% From 53,750,000 To 49,750,000 Shares; Amazon By 27% From 5,100,000 To 3,700,000 Shares; Danaher Corp By 5% From 2,050,000 To 1,950,000 Shares; Vistra Corp By 29% From 4,470,000 To 3,175,000 Shares; Microsoft By 45% From 1,580,000 To 870,000 Shares; Meta Platforms By 50% From 1,100,000  To 545,000 Shares; TSM By 12% From 2,025,000 To 1,780,000 Shares; Apple By 52% From 1,950,000 To 930,000 Shares; Amphenol Corp By 43% From 2,800,000 To 1,600,000 Shares

AISP

Airship AI shares are trading lower after the company reported worse-than-expected Q3 revenue results.

ADSK

MTCH

Starboard Value's Q3 2024 13F Filing Reveals New Stakes In Autodesk With 1.85M Shares, Match Group With 9.56M Shares

SEC Chairman Gary Gensler on Thursday defended his regulatory approach to crypto markets, emphasizing investor protection and compliance, as he hinted at an end of his stint as <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41883348/donald-trump-cant-fire-gary-gensler-but-pro-crypto-policies-means-industry-is-on-the-verge-of-a-golden-era">the agency&#8217;s chair</a>.
What Happened: In his remarks at the Practicing Law Institute&#8217;s 56th Annual Institute on Securities Regulation, Gensler <a href="https://www.sec.gov/newsroom/speeches-statements/gensler-remarks-pli-s-56th-annual-institute-securities-regulation-111424">noted</a> that his agenda builds on the SEC's history of oversight in crypto, referencing cases like Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), and emphasized the consistency of the Commission's actions over the years.
He said that since 2018, around 5-7% of SEC enforcement has been directed toward digital assets, maintaining that the agency&#8217;s approach targets specific non-compliant participants rather than the entire crypto market. 
He affirmed that "court after court" has upheld the SEC's jurisdiction over offerings that involve securities, even in digital forms.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41985685/investor-loses-25m-due-to-misplaced-crypto-transfer-says-cexs-feel-more-secure">Investor Loses $25M Due To Misplaced Crypto Transfer, Says CEXs Feel More Secure</a>
"Everything we've done is focused on ensuring compliance with our laws," Gensler said. 
He added that investor protection, through disclosure and oversight, has been a central priority, adding that compliance fosters market trust. 
Highlighting the SEC's endorsement of Bitcoin futures ETFs in 2021 and later Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) products, Gensler claimed these regulated products provided benefits such as lower fees and enhanced transparency, distinguishing them from the broader crypto markets.
His also noted that while Bitcoin, Ether, and stablecoins comprise a large portion of the crypto market, other assets—often speculative—had yet to demonstrate enduring use cases.
Gensler closed with thanking the team at the Securities and Exchange Commission, emphasizing it has been a &#8220;great honor to serve with them, doing the people's work and ensuring that our capital markets remain the best in the world.&#8221;
What&#8217;s Next: As Gensler&#8217;s term draws to a close, his approach remains influential. His remarks come as the digital asset community gathers insights at events like Benzinga's <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> conference on Nov. 19, where regulatory and innovation discussions continue to unfold.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41984505/bitcoin-to-peak-at-180000-says-vanecks-head-of-digital-assets-research">Bitcoin To Peak At $180,000, Says VanEck&#8217;s Head Of Digital Assets Research</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

Gary Gensler Hints At Ending His Stint As SEC Chair, Defends Crypto Regulation Agenda

ONCT

Oncternal Therapeutics Announced Workforce Reduction Effective December 2, 2024; Four Employees Will Remain In A Part-time Capacity In Connection With Exploration Of Strategic Alternatives; Expects $2.4M In Charges From Workforce Reduction

Health Catalyst signs definitive agreement to acquire Intraprise Health

Sees Q4 adjusted EBITDA between $6.8 million and $8.8 million. Published first on TheFly – the ultimate source for real-time, market-moving breakin...

Health Catalyst sees Q4  revenue 78M-$84M, consensus $80.69M

Sees FY24 adjusted EBITDA between $25.0 million and $27.0 million. Published first on TheFly – the ultimate source for real-time, market-moving bre...

Health Catalyst sees FY24 revenue $305M- $311M, consensus $307.49M

Health Catalyst (HCAT) announced a new partnership with CyncHealth, the designated statewide health information exchange for Iowa. This partnership...

Health Catalyst announces partnership with CyncHealth

Health Catalyst Non-GAAP EPS of $0.07 misses by $0.02, revenue of $76.4M in-line

Health Catalyst, Inc. (HCAT) Q3 2024 Earnings Call Transcript

In a report released today, Stephanie Davis from Barclays maintained a Buy rating on Health Catalyst (HCAT – Research Report), with a price target ...

Barclays Sticks to Their Buy Rating for Health Catalyst (HCAT)

Analyst David Larsen of BTIG maintained a Buy rating on Health Catalyst (HCAT – Research Report), retaining the price target of $13.00. David Larse...

Health Catalyst Poised for Growth: Strong Q3 Performance and Strategic Positioning Drive Buy Rating

Health Catalyst ( ($HCAT) ) has released its Q3 earnings. Here is a breakdown of the information Health Catalyst presented to its investors. Health...

Health Catalyst Reports Q3 Revenue Growth Amid Reduced Losses

Stephens analyst Jeff Garro raised the firm's price target on Health Catalyst (HCAT) to $9 from $7 and keeps an Equal Weight rating on the shares f...

Health Catalyst price target raised to $9 from $7 at Stephens

HCAT

Press Releases

Health Catalyst Announces Partnership Expansion with Western U.S.'s Largest Health Information Exchange, Contexture

Health Catalyst and South Dakota Health Link Expand Partnership to Improve the Quality and Effectiveness of Healthcare in the Midwest

WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite

Health Catalyst to Participate in Upcoming Investor Conferences

Health Catalyst to Announce Third Quarter 2024 Operating Results and Host Conference Call on Wednesday, November 6, 2024

Health Catalyst Reports Third Quarter 2024 Results

Health Catalyst Signs Definitive Agreement to Acquire Top-Rated Cybersecurity Provider, Intraprise Health

Nationally Recognized Healthcare Executive Dr. Jill Hoggard Green Joins Health Catalyst Board of Directors

Comments

Health Catalyst

Noticias

Últimas noticias sobre Health Catalyst (NASDAQ:HCAT) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL